Atlas Trials

Efficacy and Safety of Immunotherapy in Non-small Cell Lung Cancer With Uncommon Histological Type

Clinical trial NCT05023837 · COMPLETED

Trial details

NCT number
NCT05023837
Sponsor
Hunan Province Tumor Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Uncommon Pathological Types of Lung Cancer
Start date
2018-03-02
Primary completion
2021-08-02
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.